Handan Alay Ayşe Albayrak
10.1590/0037-8682-0112-2020
Rev Soc Bras Med Trop
2020;53:e20200112.
CC BY
https://pubmed.ncbi.nlm.nih.gov/32491102/
Antitubercular Agents / therapeutic use Cerebrum / diagnostic imaging Ethambutol / therapeutic use Mycobacterium tuberculosis / isolation & purification Pyrazinamide / therapeutic use Rifampin / therapeutic use Tuberculoma / drug therapy Tuberculosis, Meningeal / drug therapy
Antitubercular Agents / therapeutic use Cerebrum / diagnostic imaging Ethambutol / therapeutic use Mycobacterium tuberculosis / isolation & purification Pyrazinamide / therapeutic use Rifampin / therapeutic use Tuberculoma / drug therapy Tuberculosis, Meningeal / drug therapy Case Reports Adult Anti-Bacterial Agents / therapeutic use Antitubercular Agents / administration & dosage Ethambutol / administration & dosage Headache / drug therapy Headache / etiology Humans Isoniazid / administration & dosage Isoniazid / therapeutic use Magnetic Resonance Imaging Male Moxifloxacin / therapeutic use Polymerase Chain Reaction Pyrazinamide / administration & dosage Rifampin / administration & dosage Treatment Outcome Tuberculoma / diagnostic imaging Tuberculosis, Meningeal / diagnosis Anti-Bacterial Agents Antitubercular Agents Pyrazinamide Ethambutol Moxifloxacin Isoniazid Rifampin
PMC7269532
32491102
Intracranial lesion increase under anti-tuberculous therapy
2020